News | Cardiovascular Ultrasound | June 19, 2019

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

Studies will be presented at the American Society of Echocardiography (ASE19) 30th Annual Scientific Session

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

June 19, 2019 — DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's LVivo EF artificial intelligence (AI)-based solution that generates fully automated left ventricular ejection fraction (LVEF). EF is a main indicator in assessing the global function of the left ventricle. Presently, many readers quantify EF visually or trace endocardial borders that may not be well defined, yielding high variability among results. LVivo EF aims to substantially reduce this variability by generating objective, accurate and fast AI-based EF.

The studies were led by Martin Goldman, M.D., Solomon Bienstock, M.D., Rajeev Samtani, M.D., Steve Liao, M.D., Usman Baber, M.D., Arieh Greenbaum, M.D., Lori B. Croft, M.D., and Eric Stern, M.D., from Mount Sinai Hospital, New York.

The first study, "Validation of a Novel Artificial Intelligence Left Ventricular Ejection Fraction Quantification Software (LVivo EF by DIA) by Cardiac MRI,"1 tested the accuracy of the LVivo EF tool on 76 patients by retrospectively running it on cardiac four-chamber clips. The LVivo EF results were then compared to those obtained by magnetic resonance imaging (MRI) EF as a gold standard. The study indicated a strong correlation between cardiac MRI and LVivo EF (R2=0.89), and it suggests that LVivo EF may be used over a wide range of cardiac function, to evaluate EF in a fast and accurate manner.

"This study further validated DiA's AI-based tool, LVivo EF, against cardiac MRI EF, a recognized gold standard for the assessment of cardiac function. Based on the study's findings, LVivo EF has the potential to provide accurate and objective quantification of LVEF to support clinicians in the decision-making process, right at the patient's bedside, saving time and resources. This is specifically important in patients with low EF, where accuracy has clinical and therapeutic implications. Moreover, by providing the endocardial border overlay on the moving images, it also facilitates immediate confirmation of its accuracy by the reader," said Goldman, associate director of the CV Institute, director of the Fellowship Training Program and director of medical education at the Icahn School of Medicine at Mount Sinai Hospital.

The successful validation of LVivo EF as compared to MRI EF, led the team to publish a second study comparing LVivo EF results to physician's evaluation of EF using transthoracic echocardiography (TTE), with and without contrast agents, entitled "Fully Automated Echocardiographic Artificial Intelligence Software (LVivo EF by DiA) Could Replace Contrast Agents for Improving Accuracy of Left Ventricular Ejection Fraction Quantification." Results indicated that in non-contrast studies compared to cardiac MRI, LVivo EF was significantly better than physicians' assessments (R2=0.823 compared to R2=0.622), while for contrast studies, which are often used to improve LVEF analysis, LVivo EF on non-contrast images and physicians' quantification of contrast-enhanced images were similar (R2=0.913 and R2=0.873).

Both studies will be presented by Bienstock at the American Society of Echocardiography (ASE) 30th Annual Scientific Session, June 22-24 in Portland, Ore.

For more information: www.dia-analysis.com

Related Content

IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 09, 2021
April 9, 2021 — According to an open-acc...
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021
April 7, 2021 — Vysioneer, a leader in a...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Videos | Point-of-Care Ultrasound (POCUS) | April 01, 2021
Here are two quick clinical examples of point-of-care ultrasound (POCUS) lung imaging and cardiac imaging using a GE
ScImage, Inc. celebrates its cloud partnership with Digirad Health (“Digirad”), a division of Star Equity Holdings, after a year of successful deployment of PICOM365 for mobile imaging. Digirad’s fleet of mobile SPECT, echocardiology, vascular and general ultrasound units combined with PICOM365’s cloud image management workflow leverage each company’s strengths to create an exemplary reading and reporting environment.
News | Archive Cloud Storage | March 30, 2021
March 30, 2021 — ScImage, Inc.
Nines announced the 510(k) FDA clearance for NinesMeasure, an innovative lung nodule measurement tool built with artificial intelligence (AI) that can accelerate diagnoses of certain respiratory diseases. 
News | Artificial Intelligence | March 30, 2021
March 30, 2021 — Nines announced the 510(k) FDA clearance for NinesMeasure, an innovative...